Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
salicylic acid
×
Overview
What is Keralyt?
DESCRIPTION:
Salicylic acid is the 2 hydroxy derivative of benzoic acid having the following structure:
What does Keralyt look like?
What are the available doses of Keralyt?
Sorry No records found.
What should I talk to my health care provider before I take Keralyt?
Sorry No records found
How should I use Keralyt?
INDICATIONS AND USAGE
DOSAGE AND ADMINISTRATION
For use as a concentrated scalp treatment BEFORE bathing:
For use as a medicated shampoo:
What interacts with Keralyt?
Sorry No Records found
What are the warnings of Keralyt?
Sorry No Records found
What are the precautions of Keralyt?
Sorry No Records found
What are the side effects of Keralyt?
Sorry No records found
What should I look out for while using Keralyt?
CONTRAINDICATIONS:
WARNINGS:
Considering the potential risk of developing Reye’s Syndrome, salicylate products should not be administered to children or teenagers with varicella or influenza, unless directed by a physician.
What might happen if I take too much Keralyt?
OVERDOSAGE
WARNINGS
How should I store and handle Keralyt?
Store at room temperature 15º-30ºC (59º-86ºF).Keep tightly closed.Store at room temperature 15º-30ºC (59º-86ºF).Keep tightly closed.HOW SUPPLIED:
×
Clinical Information
Chemical Structure
No Image found
Clinical Pharmacology
CLINICAL PHARMACOLOGY:
The major metabolites identified in the urine after topical administration are salicyluric acid (52%), salicylate glucuronides (42%), and free salicylic acid (6%). The urinary metabolites after percutaneous absorption differ from those after oral salicylate administration; those derived from percutaneous absorption contain more glucuronides and less salicyluric and salicylic acid. Almost 95% of a single dose of salicylate is excreted within 24 hours of its entrance into the extracellular space.
Fifty to eighty percent of salicylate is protein bound to albumin. Salicylates compete with the binding of several drugs and can modify the action of these drugs. By similar competitive mechanisms other drugs can influence the serum levels of salicylate. (See ).
Non-Clinical Toxicology
CONTRAINDICATIONS:
WARNINGS:
Considering the potential risk of developing Reye’s Syndrome, salicylate products should not be administered to children or teenagers with varicella or influenza, unless directed by a physician.
Drug Interactions.
I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur:
II. Drugs changing salicylate levels by altering renal tubular reabsorption:
III. Drugs with complicated interactions with salicylates:
The following alterations of laboratory tests have been reported during salicylate therapy:
PRECAUTIONS:
Keep this and all medications out of reach of children.
ADVERSE REACTIONS:
×
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Clonazepam Description
Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake.
Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula:
C15H10ClN3O3 M.W. 315.72
×
Tips
Tips
×
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib).
228 major drug interactions (854 brand and generic names)
210 moderate drug interactions (691 brand and generic names)
2 minor drug interactions (4 brand and generic names)
Show all medications in the database that may interact with Imbruvica (ibrutinib).
